Senior insider sale
President and CEO at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$4.77M
8.86K shares
What this filing means
SIBOLD WILLIAM JOHN plans to sell 8.86K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $4.77M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/9/2026ACC: 0001628280-26-061190
DirectorOfficer· President and CEO
Since Mar 2026
8.86K
Shares to sell
$4.77M
Approx. market value
6.36K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Grant
Vesting of Restricted Stock Units
9/8/2026
6.36KTotal acquired6.36K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/8/2026 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 6.36K | — |
| Total | 6.36K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.50K
Market value
$1.37M
7/20/2026
Planned — Approximate Date
Nasdaq Stock MarketPlanned
Units to sell
6.36K
Market value
$3.40M
9/9/2026
Total
Units
8.86K
Value
$4.77M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/20/2026 | 2.50K | $1.37M | — | Completed |
| Planned — Approximate Date | ||||
9/9/2026 | 6.36K | $3.40M | Nasdaq Stock Market | Planned |
| Total | 8.86K | $4.77M | ||